Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Increased by Mizuho Securities USA LLC

Mizuho Securities USA LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,180 shares of the medical equipment provider's stock after purchasing an additional 1,835 shares during the quarter. Mizuho Securities USA LLC's holdings in Intuitive Surgical were worth $14,335,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares during the period. LRI Investments LLC acquired a new stake in Intuitive Surgical in the first quarter valued at approximately $30,000. Finally, LGT Financial Advisors LLC raised its holdings in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 54 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock traded down $10.19 during trading hours on Friday, reaching $527.61. 1,447,901 shares of the stock were exchanged, compared to its average volume of 1,417,223. Intuitive Surgical, Inc. has a 12-month low of $295.02 and a 12-month high of $544.38. The business's fifty day moving average is $499.29 and its two-hundred day moving average is $457.89. The firm has a market capitalization of $187.92 billion, a P/E ratio of 84.82, a P/E/G ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Mark Brosius sold 2,115 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the sale, the insider now owns 295 shares in the company, valued at approximately $145,113.45. This trade represents a 87.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 396 shares of the business's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $486.88, for a total value of $192,804.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,680,761.28. This trade represents a 6.71 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 91,178 shares of company stock worth $45,897,071. Company insiders own 0.90% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ISRG. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. Mizuho raised their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Truist Financial lifted their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Redburn Atlantic raised Intuitive Surgical from a "neutral" rating to a "buy" rating and increased their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Finally, Raymond James boosted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.